Switch to:
More From Other Websites
Exelixis to Release First Quarter 2016 Financial Results on Wednesday, May 4, 2016 Apr 26 2016
Exelixis to Release First Quarter 2016 Financial Results on Wednesday, May 4, 2016 Apr 26 2016
Pay Attention to These 5 Stocks Making Big Moves Today Apr 26 2016
Ipsen is pleased to announce that its partner Exelixis obtained FDA Approval of CABOMETYX™... Apr 26 2016
ADDING MULTIMEDIA Exelixis Announces FDA Approval of CABOMETYX™ (Cabozantinib) Tablets for... Apr 25 2016
Peninsula drug developer scores comeback win for cancer-fighting tablet Apr 25 2016
ADDING MULTIMEDIA Exelixis Announces FDA Approval of CABOMETYX™ (Cabozantinib) Tablets for... Apr 25 2016
Exelixis, Inc. Conference Call to Discuss U.S. FDA Approval of CABOMETYX Tablets scheduled for 4:00... Apr 25 2016
Exelixis Gets FDA Approval For Its CABOMETYX Tablets Apr 25 2016
Exelixis Announces FDA Approval of CABOMETYX™ (Cabozantinib) Tablets for Patients with Advanced... Apr 25 2016
Why Are These Stocks Trading Deep in Red on Friday? Apr 22 2016
Exelixis-Discovered Compounds to Be Featured in 18 Presentations at 2016 ASCO Annual Meeting Apr 20 2016
Exelixis-Discovered Compounds to Be Featured in 18 Presentations at 2016 ASCO Annual Meeting Apr 20 2016
Exelixis, Inc. breached its 50 day moving average in a Bullish Manner : EXEL-US : April 5, 2016 Apr 05 2016
Exelixis (EXEL) Stock Climbs, Stifel Upgrades Apr 04 2016
Exelixis upgraded by Stifel Apr 04 2016
Are These Biotech Stocks Worth your Attention? CELG, ARIA, EXEL, and CMRX Mar 22 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK